ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. Glenmark Pharmaceuticals has recalled two dozen generic ...

Glenmark is set to launch a generic version of Teva’s Adderall tablets in strengths ranging from 5 mg to 30 mg, with distribution set to begin in May 2025. The company will launch ...

(Judgment paragraphs 56-58). Damages were not an adequate remedy for Glenmark (or the NHS) either - but it was prudent to preserve the status quo. AZ’s arguments on ground 3 (including an ...

Glenmark gave no potential launch date for the generic approved by the FDA at 5 mg and 10 mg strengths. AZ did not mention the impact of generic competition for Farxiga in the US in its full year ...

Glenmark Pharmaceuticals has voluntarily recalled 24 generic prescription drugs distributed in the U.S. following concerns about potential cross-contamination at a manufacturing facility in ...

Glenmark Pharmaceuticals Ltd., one of the Indian drugmakers, said that its US-based subsidiary will bring ADHD treatment tablets into the US market by May 2025. The drug consists of a combination ...

This article originally appeared on ProPublica. ProPublica is a Pulitzer Prize-winning investigative newsroom. Sign up for The Big Story newsletter to receive stories like this one in your inbox.